Determination of c-erbB-2 Protein in Primary Breast Cancer Tissue Extract Using an Enzyme Immunoassay-Reference-Cited by-同舟云学术

Determination of c-erbB-2 Protein in Primary Breast Cancer Tissue Extract Using an Enzyme Immunoassay

Published:1993-12 Issue:12 Volume:84 Page:1279-1286
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Watanabe Toru,Fukutomi Takashi,Tsuda Hitoshi,Adachi Isamu,Nanasawa Takeshi,Yamamoto Hiroshi,Abe Kaoru

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1993.tb02835.x/fullpdf

Reference37 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Treatment decisions in axillary node-negative breast cancer patients;McGuire;J. Natl. Cancer Inst. Monogr.,1992

3. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene;Singleton;Pathol. Annu.,1992

4. Neu-protein overexpression in breast cancer. Association with comedotype ductal carcinoma in situ and limited prognostic value in stage II breast cancer;Vijver;N. Engl. J. Med.,1988

5. Follow-up study of HER-2/neu amplification in primary breast cancer;Clark;Cancer Res.,1991

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer;Breast Cancer Research and Treatment;2014-04-06

2. A mechanism of drug resistance to tamoxifen in breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2002-12

3. Differences in the Progesterone Receptor Contents Between Familial Breast Cancers and Sporadic Breast Cancers Stratified by Patient Age;Surgery Today;2001-11-01

4. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.;Endocrine-related cancer;2001-03

5. Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment;The Breast;2001-02